Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
178.3 USD | +0.63% | +5.30% | +44.12% |
Mar. 12 | Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing | MT |
Mar. 12 | Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.12% | 5.01B | |
+2.86% | 108B | |
+9.54% | 104B | |
+6.58% | 23.66B | |
-11.97% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.26% | 16.19B | |
+4.18% | 13.72B | |
+33.35% | 12.22B |
- Stock
- Equities
- Stock Krystal Biotech, Inc. - Nasdaq
- News Krystal Biotech, Inc.
- Krystal Biotech : Completes Enrollment of Phase 3 Study of B-VEC to Treat Dystrophic Epidermolysis Bullosa